Atacicept in Subjects With Optic Neuritis

Summary

This study was intended to evaluate the efficacy, safety and tolerability of atacicept compared to placebo and to explore the neuroprotective effect of atacicept as assessed by OCT in subjects with ON as CIS. The study was randomized. Study medication was administered via subcutaneous (under the skin) injections.

Timeline

Start

2008-06

Primary completion

2009-09

Completion

2011-01

Drugs

Indications